Item Type | Name |
Academic Article
|
Plasma concentrations of immunoreactive atrial natriuretic peptide in hospitalized cirrhotic and noncirrhotic patients: evidence for a role of deficient atrial natriuretic peptide in pathogenesis of cirrhotic ascites.
|
Concept
|
Liver Diseases
|
Concept
|
Liver Cirrhosis
|
Concept
|
Liver
|
Concept
|
Liver Transplantation
|
Concept
|
Liver Function Tests
|
Concept
|
Liver Diseases, Alcoholic
|
Concept
|
Fatty Liver, Alcoholic
|
Concept
|
Liver Glycogen
|
Concept
|
Mitochondria, Liver
|
Concept
|
Liver Neoplasms
|
Concept
|
Microsomes, Liver
|
Concept
|
Liver Circulation
|
Concept
|
Liver Cirrhosis, Biliary
|
Concept
|
Liver Regeneration
|
Concept
|
Liver Failure
|
Concept
|
Fatty Liver
|
Concept
|
Liver Failure, Acute
|
Academic Article
|
Porphyrogenic properties of the terpenes camphor, pinene, and thujone (with a note on historic implications for absinthe and the illness of Vincent van Gogh).
|
Academic Article
|
Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools.
|
Academic Article
|
Iron and the liver.
|
Academic Article
|
Activation of the hepatocarcinogen aflatoxin B1 by forms of human hepatic cytochromes P-450: some do and some don't.
|
Academic Article
|
A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function.
|
Academic Article
|
Osteocalcin and bone alkaline phosphatase in the serum of women with liver disease.
|
Academic Article
|
Immunochemical studies of haem oxygenase. Preparation and characterization of antibodies to chick liver haem oxygenase and their use in detecting and quantifying amounts of haem oxygenase protein.
|
Academic Article
|
Synergistic induction of delta-aminolevulinate synthase by glutethimide and iron: relationship to the synergistic induction of heme oxygenase.
|
Academic Article
|
Cloning, sequencing and expression of cDNA for chick liver haem oxygenase. Comparison of avian and mammalian cDNAs and deduced proteins.
|
Academic Article
|
Purification and characterization of heme oxygenase from chick liver. Comparison of the avian and mammalian enzymes.
|
Academic Article
|
Antibodies against mitochondrial dehydrogenase complexes in primary biliary cirrhosis.
|
Academic Article
|
Mechanism of synergistic induction of hepatic heme oxygenase by glutethimide and iron: studies in cultured chick embryo liver cells.
|
Academic Article
|
Prevalence and prediction of osteopenia in chronic liver disease.
|
Academic Article
|
Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease.
|
Academic Article
|
Choline may be an essential nutrient in malnourished patients with cirrhosis.
|
Academic Article
|
The porphyrias.
|
Academic Article
|
Atenolol for prevention of rebleeding from esophageal varices in hepatic cirrhosis: results of a controlled, randomized pilot study.
|
Academic Article
|
Heme catabolism in cultured hepatocytes: evidence that heme oxygenase is the predominant pathway and that a proportion of synthesized heme is converted rapidly to biliverdin.
|
Academic Article
|
Mechanism of iron potentiation of hepatic uroporphyria: studies in cultured chick embryo liver cells.
|
Academic Article
|
Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda.
|
Academic Article
|
Immunochemical detection of different isoenzymes of cytochrome P-450 induced in chick hepatocyte cultures.
|
Academic Article
|
Hepatic microsomal function in rats with chronic dietary iron overload.
|
Academic Article
|
Uroporphyrin accumulation produced by halogenated biphenyls in chick-embryo hepatocytes. Reversal of the accumulation by piperonyl butoxide.
|
Academic Article
|
Hepatic heme and drug metabolism in rats with chronic mountain sickness.
|
Academic Article
|
Role of cytochrome P-450 in porphyria caused by halogenated aromatic compounds.
|
Academic Article
|
Regulation of hepatic haem metabolism. Disparate mechanisms of induction of haem oxygenase by drugs and metals.
|
Academic Article
|
Tryptophan 2,3-dioxygenase in chick embryo hepatocytes: studies in ovo and in culture.
|
Academic Article
|
Microassay of heme oxygenase by high-performance liquid chromatography: application to assay of needle biopsies of human liver.
|
Academic Article
|
Haem synthesis from exogenous 5-aminolaevulinate in cultured chick-embryo hepatocytes. Effects of inducers of cytochromes P-450.
|
Academic Article
|
Induction of porphyria in cultured chick-embryo hepatocytes by halogenated aromatic compounds.
|
Academic Article
|
Hepatic heme synthesis in a new model of experimental hemochromatosis: studies in rats fed finely divided elemental iron.
|
Academic Article
|
High-performance liquid chromatographic separation and quantitation of tetrapyrroles from biological materials.
|
Academic Article
|
Induction of 5-aminolaevulinate synthase by two- to five-carbon alcohols in cultured chick-embryo hepatocytes. Relationship to induction of cytochrome P-450.
|
Academic Article
|
Fatal liver failure in protoporphyria. Synergism between ethanol excess and the genetic defect.
|
Academic Article
|
Severe liver injury due to phenelzine with unique hepatic deposition of extracellular material.
|
Academic Article
|
Cytochrome P450 of small intestinal epithelial cells. Immunochemical characterization of the increase in cytochrome P450 caused by phenobarbital.
|
Academic Article
|
Conversion of 5-aminolaevulinate into haem by homogenates of human liver. Comparison with rat and chick-embryo liver homogenates.
|
Academic Article
|
Increased glutathione in cultured hepatocytes associated with induction of cytochrome P-450. Lack of effect of glutathione depletion on induction of cytochrome P-450 and delta-aminolevulinate synthase.
|
Academic Article
|
Inhibition of uroporphyrinogen decarboxylase by halogenated biphenyls in chick hepatocyte cultures. Essential role for induction of cytochrome P-448.
|
Academic Article
|
Formation of cytochrome P-450 containing haem or cobalt-protoporphyrin in liver homogenates of rats treated with phenobarbital and allylisopropylacetamide.
|
Academic Article
|
Effect of uroporphyrin on the spectral measurement of cytochrome P450.
|
Academic Article
|
Effect of hemochromatosis on hepatic cytochrome P450 and antipyrine metabolism in humans.
|
Academic Article
|
High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.
|
Academic Article
|
Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy.
|
Academic Article
|
A detailed analysis of the Knodell score and other histologic parameters as predictors of response to interferon therapy in chronic hepatitis C.
|
Academic Article
|
Putting the freeze on hepatitis C virus-associated mixed cryoglobulinemia.
|
Academic Article
|
Effects of mifepristone (RU-486) on heme metabolism and cytochromes P-450 in cultured chick embryo liver cells, possible implications for acute porphyria.
|
Academic Article
|
Repression of ALA synthase by heme and zinc-mesoporphyrin in a chick embryo liver cell culture model of acute porphyria.
|
Academic Article
|
Differential effects of metalloporphyrins on messenger RNA levels of delta-aminolevulinate synthase and heme oxygenase. Studies in cultured chick embryo liver cells.
|
Academic Article
|
Effects of hemopexin on heme-mediated repression of 5-aminolevulinate synthase and induction of heme oxygenase in cultured hepatocytes.
|
Academic Article
|
Acute hepatic and renal toxicity from low doses of acetaminophen in the absence of alcohol abuse or malnutrition: evidence for increased susceptibility to drug toxicity due to cardiopulmonary and renal insufficiency.
|
Academic Article
|
3,5,5-Trimethylhexanoylferrocene induction of heme oxygenase activity in normal hepatocytes.
|
Academic Article
|
Nutritional supplementation in chronic liver disease: an analytical review.
|
Academic Article
|
Repression of hepatic delta-aminolevulinate synthase by heme and metalloporphyrins: relationship to inhibition of heme oxygenase.
|
Academic Article
|
Molecular basis for heme-dependent induction of heme oxygenase in primary cultures of chick embryo hepatocytes. Demonstration of acquired refractoriness to heme.
|
Academic Article
|
Induction of heme oxygenase-1 in LMH cells. Comparison of LMH cells to primary cultures of chick embryo liver cells.
|
Academic Article
|
Iron in liver diseases other than hemochromatosis.
|
Academic Article
|
Effect of interferon therapy on bile duct inflammation in hepatitis C.
|
Academic Article
|
An update on iron metabolism: summary of the Fifth International Conference on Disorders of Iron Metabolism.
|
Academic Article
|
Hepatic 5-aminolevulinic acid synthase mRNA stability is modulated by inhibitors of heme biosynthesis and by metalloporphyrins.
|
Academic Article
|
Regulation of metallothionein gene expression. Studies in transfected primary cultures of chick embryo liver cells.
|
Academic Article
|
Haemopexin and uptake of haem by liver cells.
|
Academic Article
|
Iron and chronic viral hepatitis.
|
Academic Article
|
Mechanism of induction of heme oxygenase by metalloporphyrins in primary chick embryo liver cells: evidence against a stress-mediated response.
|
Academic Article
|
Effects of new anticonvulsant medications on porphyrin synthesis in cultured liver cells: potential implications for patients with acute porphyria.
|
Academic Article
|
Regulation of expression of the human heme oxygenase-1 gene in transfected chick embryo liver cell cultures.
|
Academic Article
|
Utility of hepatic iron index in American patients with hereditary hemochromatosis: a multicenter study.
|
Academic Article
|
Inflammatory markers in chronic hepatitis C.
|
Academic Article
|
Frequency and distribution of DNA fragmentation as a marker of cell death in chronic liver diseases.
|
Academic Article
|
Molecular cloning, characterization, and expression of the chicken heme oxygenase-1 gene in transfected primary cultures of chick embryo liver cells.
|
Academic Article
|
Diagnosis of porphyric syndromes: a practical approach in the era of molecular biology.
|
Academic Article
|
Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells. Role of mitogen-activated protein kinases.
|
Academic Article
|
Enhanced phenotypic expression of alpha-1-antitrypsin deficiency in an MZ heterozygote with chronic hepatitis C.
|
Academic Article
|
Inefficient recognition of autologous viral sequences by intrahepatic hepatitis C virus-specific cytotoxic T lymphocytes in chronically infected subjects.
|
Academic Article
|
The value of intravenous heme-albumin and plasmapheresis in reducing postoperative complications of orthotopic liver transplantation for erythropoietic protoporphyria.
|
Academic Article
|
Increased heme oxygenase-1 gene expression in liver cells and splanchnic organs from portal hypertensive rats.
|
Academic Article
|
Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques.
|
Academic Article
|
Effects of selected antihypertensives and analgesics on hepatic porphyrin accumulation: implications for clinical porphyria.
|
Academic Article
|
Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.
|
Academic Article
|
IFN-alpha receptor mRNA expression in a United States sample with predominantly genotype 1a/I chronic hepatitis C liver biopsies correlates with response to IFN therapy.
|
Academic Article
|
Heme biosynthesis in a chicken hepatoma cell line (LMH): comparison with primary chick embryo liver cells (CELC).
|
Academic Article
|
Effects of antidepressants and benzodiazepine-type anxiolytic agents on hepatic porphyrin accumulation in primary cultures of chick embryo liver cells.
|
Academic Article
|
Effects of phenylarsine oxide on expression of heme oxygenase-1 reporter constructs in transiently transfected cultures of chick embryo liver cells.
|
Academic Article
|
Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration.
|
Academic Article
|
Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial.
|
Academic Article
|
Upstream regulatory elements in chick heme oxygenase-1 promoter: a study in primary cultures of chick embryo liver cells.
|
Academic Article
|
Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis.
|
Academic Article
|
Zebrafish dracula encodes ferrochelatase and its mutation provides a model for erythropoietic protoporphyria.
|
Academic Article
|
Management of recurrent hepatitis C after liver transplantation: a concise review.
|
Academic Article
|
Hepatic iron concentration and total body iron stores in thalassemia major.
|
Academic Article
|
Iron-induced liver injury.
|
Academic Article
|
Ubiquitin as a marker of cell injury in nonalcoholic steatohepatitis.
|
Academic Article
|
Extrahepatic manifestations of infection with hepatitis C virus.
|
Academic Article
|
Induction of heme oxygenase-1 by phenylarsine oxide. Studies in cultured primary liver cells.
|
Academic Article
|
Benefits of chronic plasmapheresis and intravenous heme-albumin in erythropoietic protoporphyria after orthotopic liver transplantation.
|
Academic Article
|
Intestinal expression of genes involved in iron absorption in humans.
|
Academic Article
|
Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone.
|
Academic Article
|
Management of nonalcoholic steatohepatitis: an analytic review.
|
Academic Article
|
Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C.
|
Academic Article
|
Optimal management of nonalcoholic fatty liver/steatohepatitis.
|
Academic Article
|
Iron as a co-morbid factor in nonhemochromatotic liver disease.
|
Academic Article
|
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.
|
Academic Article
|
Hepatic porphyrias: diagnosis and management.
|
Academic Article
|
Role of Bach-1 in regulation of heme oxygenase-1 in human liver cells: insights from studies with small interfering RNAS.
|
Academic Article
|
Fatal air and bile embolism after percutaneous liver biopsy and ERCP.
|
Academic Article
|
Association of hepatitis C virus infection with serum iron status: analysis of data from the third National Health and Nutrition Examination Survey.
|
Academic Article
|
Evolution of the intrahepatic T cell repertoire during chronic hepatitis C virus infection.
|
Academic Article
|
Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.
|
Academic Article
|
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.
|
Academic Article
|
Iron in nonhemochromatotic liver disorders.
|
Academic Article
|
Liver transplantation for erythropoietic protoporphyria liver disease.
|
Academic Article
|
Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis).
|
Academic Article
|
Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C.
|
Academic Article
|
HCV proteins increase expression of heme oxygenase-1 (HO-1) and decrease expression of Bach1 in human hepatoma cells.
|
Academic Article
|
Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): a growing concern.
|
Academic Article
|
HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial.
|
Academic Article
|
Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
|
Academic Article
|
Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.
|
Academic Article
|
Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis.
|
Academic Article
|
Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.
|
Academic Article
|
Genetic aspects of porphyria cutanea tarda.
|
Academic Article
|
Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
Academic Article
|
Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a meta-analysis of six prospective randomized controlled trials.
|
Academic Article
|
Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.
|
Academic Article
|
Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
|
Academic Article
|
Vascular endothelium as a contributor of plasma sphingosine 1-phosphate.
|
Academic Article
|
Tissue-specific expression of ALA synthase-1 and heme oxygenase-1 and their expression in livers of rats chronically exposed to ethanol.
|
Academic Article
|
Effects of silymarin on hepatitis C virus and haem oxygenase-1 gene expression in human hepatoma cells.
|
Academic Article
|
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.
|
Academic Article
|
Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.
|
Academic Article
|
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.
|
Academic Article
|
Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis.
|
Academic Article
|
Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.
|
Academic Article
|
Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
|
Academic Article
|
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
Academic Article
|
Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
Academic Article
|
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.
|
Academic Article
|
Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.
|
Academic Article
|
Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C.
|
Academic Article
|
Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells.
|
Academic Article
|
Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trial.
|
Academic Article
|
Drug-induced liver injury associated with statins.
|
Academic Article
|
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.
|
Academic Article
|
Zinc mesoporphyrin induces rapid proteasomal degradation of hepatitis C nonstructural 5A protein in human hepatoma cells.
|
Academic Article
|
Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis C.
|
Academic Article
|
Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
Academic Article
|
MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins.
|
Academic Article
|
Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.
|
Academic Article
|
Outcome of sustained virological responders with histologically advanced chronic hepatitis C.
|
Academic Article
|
Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.
|
Academic Article
|
Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network.
|
Academic Article
|
Parallel microRNA and mRNA expression profiling of (genotype 1b) human hepatoma cells expressing hepatitis C virus.
|
Academic Article
|
Effect of bovine serum albumin on mitochondrial respiration in the brain and liver of mice and rats.
|
Academic Article
|
Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C.
|
Academic Article
|
Development and progression of portal hypertensive gastropathy in patients with chronic hepatitis C.
|
Academic Article
|
Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon.
|
Academic Article
|
microRNAs: fad or future of liver disease.
|
Academic Article
|
Lon peptidase 1 (LONP1)-dependent breakdown of mitochondrial 5-aminolevulinic acid synthase protein by heme in human liver cells.
|
Academic Article
|
Mallory-Denk bodies are associated with outcomes and histologic features in patients with chronic hepatitis C.
|
Academic Article
|
Subcellular tissue proteomics of hepatocellular carcinoma for molecular signature discovery.
|
Academic Article
|
YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C.
|
Academic Article
|
Neonatal androgenization exacerbates alcohol-induced liver injury in adult rats, an effect abrogated by estrogen.
|
Academic Article
|
Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.
|
Academic Article
|
Serum proteomic profiling in patients with drug-induced liver injury.
|
Academic Article
|
Hepatitis C, porphyria cutanea tarda and liver iron: an update.
|
Academic Article
|
Antigen-specific T lymphocyte proliferation decreases over time in advanced chronic hepatitis C.
|
Academic Article
|
Acute liver injury due to flavocoxid (Limbrel), a medical food for osteoarthritis: a case series.
|
Academic Article
|
Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs.
|
Academic Article
|
Identification of differentially expressed proteins from primary versus metastatic pancreatic cancer cells using subcellular proteomics.
|
Academic Article
|
Risk factors for porphyria cutanea tarda -the iron/HFE connection.
|
Academic Article
|
Liver injury from tumor necrosis factor-a antagonists: analysis of thirty-four cases.
|
Academic Article
|
Cytoskeletal proteins: shaping progression of hepatitis C virus-induced liver disease.
|
Academic Article
|
Presentation and outcomes with clinically apparent interferon beta hepatotoxicity.
|
Academic Article
|
Chronic hepatitis E with neurologic manifestations and rapid progression of liver fibrosis in a liver transplant recipient.
|
Academic Article
|
Heme status affects human hepatic messenger RNA and microRNA expression.
|
Academic Article
|
Catechins in dietary supplements and hepatotoxicity.
|
Academic Article
|
Intravenous interferon administered during liver transplantation is not effective in preventing hepatitis C reinfection.
|
Academic Article
|
Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.
|
Academic Article
|
Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
|
Academic Article
|
Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance.
|
Academic Article
|
Novel role of nuclear receptor Rev-erba in hepatic stellate cell activation: potential therapeutic target for liver injury.
|
Academic Article
|
Hepatotoxicity of anti-TNF agents.
|
Academic Article
|
Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network.
|
Academic Article
|
Statins and liver injury.
|
Academic Article
|
Indications for liver transplant and AASLD guidelines.
|
Academic Article
|
Drug-induced liver injury with autoimmune features.
|
Academic Article
|
ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury.
|
Academic Article
|
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network.
|
Academic Article
|
Hepatitis B and liver transplantation: molecular and clinical features that influence recurrence and outcome.
|
Academic Article
|
Herbal dietary supplement associated hepatotoxicity: an upcoming workshop and need for research.
|
Academic Article
|
MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA.
|
Academic Article
|
Herbal products and the liver: a review of adverse effects and mechanisms.
|
Academic Article
|
On stress and the liver: a chicken and egg conundrum.
|
Academic Article
|
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.
|
Academic Article
|
Risk factors for severe or fatal drug-induced liver injury from amoxicillin-clavulanic acid.
|
Academic Article
|
Differences in glycogen, lipids, and enzymes in livers from rats flown on COSMOS 2044.
|
Academic Article
|
Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis.
|
Academic Article
|
Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis.
|
Academic Article
|
Recent insights into the biological functions of liver fatty acid binding protein 1.
|
Academic Article
|
Hepatotoxicity Associated with the Use of Anti-TNF-a Agents.
|
Academic Article
|
Amoxicillin-Clavulanate-Induced Liver Injury.
|
Academic Article
|
Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.
|
Academic Article
|
Profiles of miRNAs in serum in severe acute drug induced liver injury and their prognostic significance.
|
Academic Article
|
BMP4 promotes metastasis of hepatocellular carcinoma by an induction of epithelial-mesenchymal transition via upregulating ID2.
|
Academic Article
|
Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements.
|
Academic Article
|
Associations of gender and a proxy of female menopausal status with histological features of drug-induced liver injury.
|
Academic Article
|
Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response.
|
Grant
|
Research Network for Drug-Induced Liver Disease
|
Grant
|
HEPATITIS C CLINICAL TRIAL-CLINICAL CENTERS
|
Grant
|
HEPATIC HEME, CYTOCHROME P-450 AND DRUG METABOLISM
|
Grant
|
Effect of Heme on mRNA and miRNA Profile
|
Academic Article
|
Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked Protoporphyria.
|
Academic Article
|
BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma.
|
Academic Article
|
miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling.
|
Academic Article
|
Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort.
|
Academic Article
|
Tumour-specific amplitude-modulated radiofrequency electromagnetic fields induce differentiation of hepatocellular carcinoma via targeting Cav3.2?T-type voltage-gated calcium channels and Ca2+ influx.
|
Academic Article
|
Correction: Cytokine profiles in acute liver injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group.
|
Academic Article
|
Porphyrin-Induced Protein Oxidation and Aggregation as a Mechanism of Porphyria-Associated Cell Injury.
|
Academic Article
|
Cytokine profiles in acute liver injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group.
|
Academic Article
|
Genetic Polymorphisms Implicated in Nonalcoholic Liver Disease or Selected Other Disorders Have No Influence on Drug-Induced Liver Injury.
|
Academic Article
|
Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors.
|
Academic Article
|
Herbal and dietary supplement hepatotoxicity.
|
Academic Article
|
Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria.
|